Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Amgen Faces Potential Lack Of Near-Commercial Assets
Company’s Q3 Call Likely To Focus On Pipeline, Not Sales
Oct 26 2020
•
By
Mandy Jackson
Amgen needs to fill revenue gaps with near-term commercial products
More from Earnings
More from Business